Professional Documents
Culture Documents
BC160402926
Assignment No 1
BT 502
Seminar I
Breast Cancer
Updated Reports
From Pakistan
Breast Cancer
01 02 03
Types of Breast Clinical Signs Risk Factors
Cancers
04 05
Diagnosis & Updated Reports
Treatment From Pakistan
Introduction
The pathophysiology of breast cancer is multidimensional and still poorly understood, but
certain risk factors are known. Advancing age and female sex are the most common risk
factors. Genetic mutations, specifically BRCA 1 and 2, account for about 10% of breast
cancers. Other known risk factors include a history of ductal carcinoma in situ, high body
mass index (BMI), first birth at age greater than 30 years or nulliparity, early menarche
(before age 13 years), family history of breast or ovarian cancer, late menopause, and
postmenopausal hormone therapy use. Among women who use postmenopausal hormone
therapy, white women and women with a normal BMI and dense breasts are at greatest
risk. Women with a history of previous chest radiation also are at an increased risk.
01 Types of Breast
Cancer
Clinical Signs
A palpable breast mass is evident in about 30% of women with breast cancer.
Visible signs associated with breast cancer include dimpling, an orange-peel
appearance (peau d'orange), erythema, edema, blistering, excoriations,
sanguineous nipple discharge, and nipple retraction. Skin changes such as peau
d'orange and blistering are strongly associated with inflammatory breast cancer
and Paget disease of the breast. Sanguineous nipple discharge is associated with
papillary breast neoplasia. Ulcerations can be seen in advanced disease.
Remember to rule out malignancy in patients being treated for mastitis or a
breast abscess that is not improving clinically.
Risk Factors
1. Non-modifiable risk factors
According to ACS, non-modifiable risk factors for breast cancer include gender, advancing age,
genetic factors, family history, race, ethnicity, dense breast tissue, tobacco smoke, certain benign
breast conditions, previous chest radiations and diethylstilbestrol exposure.
2. Modifiable risk factors
Lifestyle-related risk factors include the number of children given birth to, birth control, hormone
therapy, breastfeeding, alcohol use, overweight or obesity and physical activity.
3. Controversial risk factors
Some factors have uncertain, controversial or unproven effect on the risk of developing breast cancer.
These factors include diet and vitamin intake, anti-perspirants, bras, induced abortions, chemicals in
the environment, and night-shift works.
Diagnosis
Mammography and ultrasonography are used as initial imaging
modalities. MRI may be used in specific circumstances, such as in
patients with dense breasts, those with a history of breast cancer, those
who are being evaluated for contralateral disease, and those at high risk
for breast cancer.7 MRI also can be used in the presurgical planning of
biopsy-proven breast cancer or in the evaluation of patients with dense
breasts, contralateral disease, or a history of breast surgery or radiation.
MRI can more accurately identify skin changes common in inflammatory
breast cancer, such as skin invasion.
Disease is confirmed by tissue biopsy; samples can be obtained through
percutaneous ultrasound-guided core needle biopsy, excisional biopsy,
stereotactic biopsy, or MRI-guided biopsy. The preferred method for
most patients is ultrasound-guided large-bore core needle biopsy with or
without a vacuum-assisted device.
Treatment
Surgery
Chemotherapy
Chemotherapeutic options depend on multiple
variables, including hormone receptor status, HER-2
status, presence or absence of metastatic disease, and Treatment of breast cancer, including surgery, depends on the size
Oncotype DX recurrence score. Locally advanced of the lesion, hormone receptivity and histologic markers, presence
disease and triple-negative breast cancer usually are or absence of metastatic or contralateral disease, patient age, and
treated with presurgical neoadjuvant chemotherapy. patient preferences. Surgical options include lumpectomy,
Chemotherapeutic agents include doxorubicin,
mastectomy, and bilateral mastectomy. Breast-conserving surgery
cyclophosphamide, and paclitaxel. Doxorubicin can
cause significant nausea, vomiting, diarrhea, and (lumpectomy) is the preferred intervention for most patients with
fatigue. Some women will experience a discoloration of unilateral disease, but many patients still opt for mastectomy.
their nails.
Updated Reports From Pakistan